Sidley Austin has advised Werewolf Therapeutics. Cooley has advised Ambros Therapeutics. Latham & Watkins has advised the placement agents. Werewolf Therapeutics, Inc. (NASDAQ: HOWL) and Ambros...
Werewolf and Ambros Therapeutics Announce All-Stock Merger and $150 Million Private Placement
Tarsus Pharmaceuticals Signs Agreement to Acquire Alkeus Pharmaceuticals
Gunderson Dettmer has advised Tarsus Pharmaceuticals. Latham & Watkins has advised Alkeus Pharmaceuticals. Tarsus Pharmaceuticals (Nasdaq: TARS) has entered into a definitive agreement to acquire Alkeus...
Vir Biotechnology Completes $172.5 Million Public Offering of Common Stock
Gunderson Dettmer, with support from Ropes & Gray LLP, Sheppard, Mullin, Richter & Hampton LLP, and Fox Rothschild LLP, has advised Vir Biotechnology. Latham & Watkins...
Marvell Announces $3.25 Billion Acquisition of Celestial AI to Bolster Data Center Connectivity
Wilson Sonsini Goodrich & Rosati has advised Marvell Technology, Skadden has advised Citi, while Latham & Watkins and Morgan Stanley have advised Celestial AI. Marvell Technology,...